Member Info for dan1nat1

Covgaz,

Don’t mistake my dig at your lazy one line deramp for a dig at you, the two are quite different.
The reason I chose to have the “dig” was on a day when we get a great RNS I don’t really expect to see “holders” posting negatively I expect that from someone looking to get in cheaper after feeling they have missed the boat.
Add your £2.50 comment to the mix and it sounds like you should have taken the hit and moved on already...if you actually believed it was going to £2.50 you could have sold and bought back cheaper.
If you didn’t believe it you must understand why I questioned your comments today.
IMO you will get your bags on this...but you might need to give it more than a couple of months ;)

Jedi, depending on when you bought you must have 3,4 or 5 bagged by now?

Not a bad return on 3 years...however my eyes are firmly set on where we can be in the next 3 years, and I think it will make my current return look terrible.

For context I have also been holding around 3 years.

Shall I acknowledge it in the same way you acknowledged you were wrong about the £2.50 prediction?

"The thing with this one now is there will be no more news for a while I would expect a drift back down to where we started today. No ssv unless they suddenly announce a partner."

Thanks Gaz but you predicted would be able to buy at £2.50 less than 2 weeks ago so please forgive me if I also think your latest post is bull****.

Based on a number of successful cohorts could we potentially have 5-6 separate P3 trials, with 5-6 partner deals all on Clevegen, or are we more likely to see one blockbuster deal?

Maybe that depends on how good the P2 trials end up looking?

So do you think we will see any partner deals before P2 is complete or will the big boys wait and be forced to pay more, with everything we have going on currently our newsflow over the next 12-18 months could be fantastic!

"So partial responders could become full responders!"

Exactly, and non responders could become at least partial...especially if we can get to the patient before all other options have been tested.

Itsall I also wonder how many of these responders had been on the increased frequency dosing...I'm expecting non and we have yet to see that data which should be even better again.

Nice to see the bid creeping up this morning, the mm's clearly need shares.

I expect we will be back to £4+ today if they don't get the shares they are looking for!

Sax I was just thinking the same thing myself, with numbers like these though it won’t be long before people start to notice and we are bumped up the priority list.

Just noticed your takeover comment oil, maybe £25 now but what if we hold out for another 6-12 months...

With numbers like these I wonder how long until the big boys come in with either a partner deal or a full on takeover!

Delayed trades totalling almost 2m shares posted after close today!
Got to be a TR1 coming soon, those numbers are to big for an average pi.

Colin it’s hard to keep track of the interviews Keith does, as they are on a few different sites.
Full NASDAQ listing was mentioned on one of those when we listed on the pink sheets over there. He didn’t put a time scale on it, but based on the pink sheet listing the demand would be there for a full listing.

Chez listing is long awaited and should help reduce the free float, but a full NASDAQ listing is when the real fun will start ;)

Maybe your posting history has everyone questioning your motives Persi?

Anyway in answer to your question a JV would not be in keeping with the stated business model, but I suppose the stated business model might not have anticipated such a result at WN.
Based on the large development costs I think we could see a JV or maybe some kind of on going royalty payment?

Dumb, I think we might need to agree to disagree. I think there are positives and negatives to both BCN and EMH, if pushed I would find it hard to say which will be my best holding.
We are just entering a golden age for EV and battery materials as a whole, there is more than enough room for both to be extremely successful and while you post as though it’s one or the other I think the increase in profile on the sector is great for both.
Your negative posting on EMH since you sold really does do you a disservice, and says to me you are not convinced by how big the lithium market will actually be in the next 3-4 years.
Given that timescale I’m expecting multi bags for both BCN and EMH.

It would have been interesting to hear more about the trials being carried out with the US Dept of Defense, regarding the prevention of multiple organ dysfunction syndrone...or did I miss that part?

Interim readout from HIBISCUS expected Q3

Confirmed starting any week now!